JP2012012402A5 - - Google Patents

Download PDF

Info

Publication number
JP2012012402A5
JP2012012402A5 JP2011178577A JP2011178577A JP2012012402A5 JP 2012012402 A5 JP2012012402 A5 JP 2012012402A5 JP 2011178577 A JP2011178577 A JP 2011178577A JP 2011178577 A JP2011178577 A JP 2011178577A JP 2012012402 A5 JP2012012402 A5 JP 2012012402A5
Authority
JP
Japan
Prior art keywords
antibody
binding
antigen
fragment
gpr
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011178577A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012012402A (ja
JP5933204B2 (ja
Filing date
Publication date
Priority claimed from US09/266,464 external-priority patent/US6329159B1/en
Application filed filed Critical
Publication of JP2012012402A publication Critical patent/JP2012012402A/ja
Publication of JP2012012402A5 publication Critical patent/JP2012012402A5/ja
Application granted granted Critical
Publication of JP5933204B2 publication Critical patent/JP5933204B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2011178577A 1999-03-11 2011-08-17 抗ｇｐｒ−９−６および抗ｔｅｃｋ抗体ならびにｇｐｒ−９−６およびｔｅｃｋの機能の調節因子の同定方法 Expired - Lifetime JP5933204B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/266,464 1999-03-11
US09/266,464 US6329159B1 (en) 1999-03-11 1999-03-11 Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2000604070A Division JP5112578B2 (ja) 1999-03-11 2000-03-10 抗ｇｐｒ−９−６および抗ｔｅｃｋ抗体ならびにｇｐｒ−９−６およびｔｅｃｋの機能の調節因子の同定方法。

Publications (3)

Publication Number Publication Date
JP2012012402A JP2012012402A (ja) 2012-01-19
JP2012012402A5 true JP2012012402A5 (Direct) 2012-10-11
JP5933204B2 JP5933204B2 (ja) 2016-06-08

Family

ID=23014693

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2000604070A Expired - Lifetime JP5112578B2 (ja) 1999-03-11 2000-03-10 抗ｇｐｒ−９−６および抗ｔｅｃｋ抗体ならびにｇｐｒ−９−６およびｔｅｃｋの機能の調節因子の同定方法。
JP2011178577A Expired - Lifetime JP5933204B2 (ja) 1999-03-11 2011-08-17 抗ｇｐｒ−９−６および抗ｔｅｃｋ抗体ならびにｇｐｒ−９−６およびｔｅｃｋの機能の調節因子の同定方法

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP2000604070A Expired - Lifetime JP5112578B2 (ja) 1999-03-11 2000-03-10 抗ｇｐｒ−９−６および抗ｔｅｃｋ抗体ならびにｇｐｒ−９−６およびｔｅｃｋの機能の調節因子の同定方法。

Country Status (7)

Country Link
US (6) US6329159B1 (Direct)
EP (1) EP1157043B2 (Direct)
JP (2) JP5112578B2 (Direct)
AT (1) ATE517123T1 (Direct)
AU (1) AU771603B2 (Direct)
CA (1) CA2365230C (Direct)
WO (1) WO2000053635A1 (Direct)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE255888T1 (de) * 1998-06-01 2003-12-15 Ortho Mcneil Pharm Inc Tetrahydronaphtalene verbindungen und deren verwendung zur behandlung von neurodegenerativen krankheiten
US20050100548A1 (en) * 2001-07-24 2005-05-12 Biogen Idec Ma Inc. BAFF, inhibitors thereof and their use in the modulation of B-cell response
US6329159B1 (en) * 1999-03-11 2001-12-11 Millennium Pharmaceuticals, Inc. Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function
US6698636B2 (en) * 2000-09-28 2004-03-02 June Angus Waist pouch
US7468253B2 (en) * 2001-06-07 2008-12-23 Chemocentryx, Inc. Method for multiple chemokine receptor screening for antagonists using RAM assay
KR100598309B1 (ko) * 2001-06-07 2006-07-10 케모센트릭스, 인크. 세포 이동성 검사
NO20013192L (no) * 2001-06-25 2002-12-27 Medinnova As Metode for monitering av T-celler
US7442512B2 (en) * 2001-11-30 2008-10-28 Chemocentryx, Inc. Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
US7871619B2 (en) * 2001-11-30 2011-01-18 Chemocentryx, Inc. Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
US7253007B2 (en) * 2001-11-30 2007-08-07 Chemocentryx, Inc. Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
US7413866B2 (en) * 2001-11-30 2008-08-19 Chemocentryx, Inc. Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
WO2003095967A2 (en) * 2002-05-14 2003-11-20 Bayer Healthcare Ag Diagnostics and therapeutics for diseases associated with chemokine receptor 9(ccr9)
WO2003099773A1 (en) 2002-05-24 2003-12-04 Millennium Pharmaceuticals, Inc. Ccr9 inhibitors and methods of use thereof
AU2003291549A1 (en) * 2002-11-15 2004-06-15 Morehouse School Of Medicine Anti-chemokine and associated receptors antibodies for inhibition of growth of neoplasms
US7964194B2 (en) * 2002-11-15 2011-06-21 Morehouse School Of Medicine Anti-chemokine and associated receptor antibodies and uses for inhibition of inflammation
US8512701B2 (en) * 2002-11-15 2013-08-20 Morehouse School Of Medicine Anti-CXCL13 and anti-CXCR5 antibodies for the prevention and treatment of cancer and cancer cell migration
US9233120B2 (en) * 2002-11-15 2016-01-12 Jyant Technologies Anti-CCL25 and anti-CCR9 antibodies for the prevention and treatment of cancer and cancer cell migration
US8658377B2 (en) 2002-11-15 2014-02-25 Morehouse School Of Medicine Detecting cancer with anti-CCL25 and anti-CCR9 antibodies
US20120135415A1 (en) * 2002-11-15 2012-05-31 Morehouse School Of Medicine Detecting cancer with anti-cxcl13 and anti-cxcr5 antibodies
MXPA05006507A (es) * 2002-12-20 2006-02-17 Chemocentryx Inhibidores de ccxckr2 expresado en tumor humano.
MXPA05011409A (es) 2003-04-23 2005-12-12 Medarex Inc Composiciones y metodos para la terapia de enfermedad inflamatoria intestinal.
US20100247540A1 (en) * 2003-10-30 2010-09-30 Chemocentryx, Inc. Methods and Compositions For Modulating Angiogenesis
ZA200608572B (en) * 2004-04-16 2008-06-25 Genentech Inc Assay for antibodies
HUE035082T2 (en) 2004-06-21 2018-05-02 Squibb & Sons Llc Interferon alpha receptor 1 antibodies and their use
ES2434852T3 (es) * 2005-04-21 2013-12-17 Chemocentryx, Inc. Anticuerpos que se unen a CCX-CKR2
HK1212448A1 (en) 2012-09-07 2016-06-10 The Governors Of The University Of Alberta Methods and compositions for diagnosis of inflammatory liver disease
EP2876114A1 (en) * 2013-11-25 2015-05-27 Consejo Superior De Investigaciones Científicas Antibodies against CCR9 and applications thereof
WO2017140793A1 (en) 2016-02-16 2017-08-24 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Modulators of ccr9 for treating tumor resistance to immune responses
US20200164068A1 (en) 2016-02-16 2020-05-28 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Modulators of tumor immune resistance for the treatment of cancer
EP4252629A3 (en) 2016-12-07 2023-12-27 Biora Therapeutics, Inc. Gastrointestinal tract detection methods, devices and systems
CA3045310A1 (en) 2016-12-14 2018-06-21 Progenity, Inc. Treatment of a disease of the gastrointestinal tract with a chemokine/chemokine receptor inhibitor
JP7482866B2 (ja) 2018-11-19 2024-05-14 ビオラ・セラピューティクス・インコーポレイテッド 生物学的治療薬による疾患処置方法およびデバイス
CN121197633A (zh) 2019-12-13 2025-12-26 比特比德科有限责任公司 用于将治疗剂递送至胃肠道的可摄取装置
CN118843478A (zh) 2022-02-03 2024-10-25 圣洛克生物制药有限公司 用于癌症的包括抗ccr9抗体和长春新碱的联合疗法
JP7368678B1 (ja) * 2023-04-26 2023-10-25 イミュニティリサーチ株式会社 Ｃｄ４＋ｔ細胞集団中の特定の細胞亜集団の相対量の測定方法
EP4578874A1 (en) * 2023-12-29 2025-07-02 SunRock Biopharma S.L. Anti-ccr9 antibody

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US18167A (en) * 1857-09-08 Improvement in blast-furnaces
US5440021A (en) * 1991-03-29 1995-08-08 Chuntharapai; Anan Antibodies to human IL-8 type B receptor
US5652133A (en) 1993-01-28 1997-07-29 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Cloning and expression of the human macrophage inflammatory protein-1.alpha.α) /rantes receptor
DK0883687T3 (da) * 1996-03-01 2005-03-07 Euroscreen Sa C-C CKR-5, CC-chemokinreceptor, derivater deraf og anvendelse deraf
US5981231A (en) 1996-06-17 1999-11-09 Human Genome Sciences, Inc. Polynucleotides encoding chemokine β-15
HUP9903711A3 (en) 1996-06-17 2001-12-28 Human Genome Sciences Inc Rock Chemokine beta-15
JP2000514295A (ja) 1996-07-05 2000-10-31 シェーリング コーポレイション 哺乳動物のケモカイン試薬
US6723520B2 (en) * 1996-07-05 2004-04-20 Schering Corporation Antibodies that bind chemokine teck
EP0925358B1 (en) * 1996-09-10 2007-04-25 Theodor-Kocher Institute Cxcr3 chemokine receptor, antibodies, nucleic acids, and methods of use
AU6132698A (en) 1997-01-23 1998-08-18 Schering Corporation Mammalian chemokines; receptors; reagents; uses
EP0878542A3 (en) * 1997-04-22 2000-04-19 Smithkline Beecham Corporation cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor
JP2001512667A (ja) * 1997-08-06 2001-08-28 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ヒトオーファンレセプターｎｔｒ−１
US6329159B1 (en) 1999-03-11 2001-12-11 Millennium Pharmaceuticals, Inc. Anti-GPR-9-6 antibodies and methods of identifying agents which modulate GPR-9-6 function
YU78601A (sh) * 1999-05-05 2005-07-19 Aventis Pharma Deutschland Gmbh. 1-(p-tienilbenzil)-imidazoli kao agonisti angiotenzin-(1-7)- receptora, postupak za njihovu proizvodnju, njihova primena i farmaceutski preparati koji ih sadrže
WO2001049325A2 (en) * 2000-01-07 2001-07-12 Stichting Klinische Farmacologie Groningen Gene therapy to promote angiogenesis and/or the treatment of heart failure
DE60314175T2 (de) 2002-11-18 2008-01-24 Chemocentryx Inc., Mountain View Arylsulfonamide

Similar Documents

Publication Publication Date Title
JP2012012402A5 (Direct)
US11685789B2 (en) CD47 antigen-binding molecules
CN109843927B (zh) 抗b7-h3抗体、其抗原结合片段及其医药用途
CN110914304B (zh) Cd96抗体、其抗原结合片段及医药用途
JP2012501669A5 (Direct)
JP2018511319A5 (Direct)
JP2019532619A5 (Direct)
TW201837056A (zh) Ｂ７－ｈ３抗體、其抗原結合片段及其醫藥用途
JP2014518883A5 (Direct)
JP2012501670A5 (Direct)
JP2013506428A5 (Direct)
JP2010533498A5 (Direct)
JP2014518615A5 (Direct)
WO2014089209A2 (en) Blood-brain barrier (bbb) penetrating dual specific binding proteins
JP2014524733A5 (Direct)
US11136411B2 (en) Method for the treatment or prevention of a disease related to vascular endothelial lipase by administering a humanized monoclonal antibody
JP2013539369A5 (Direct)
JP2018518151A5 (Direct)
JP2005528914A5 (Direct)
CN117062834A (zh) Gpc3人源化抗体及其应用
CN113227148B (zh) 抗gpc3抗体、其抗原结合片段及其医药用途
JP2015508056A5 (Direct)
CN112094348B (zh) 抗人Tim3抗体或其功能性片段及其应用
WO2019086574A1 (en) Cd47 and cd33 antigen-binding molecules
IL283890B2 (en) Anti-periostin antibodies and uses thereof